tiprankstipranks

Jason Raleigh Nunn Insider Profile

4 Followers
Jason Raleigh Nunn, Director at Hyperion Therapeutics, holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX), holds ― shares in Regulus (Ticker: RGLS), holds 6.00K shares in Journey Medical Corp (Ticker: DERM).
tipranks
Jason Raleigh Nunn

Jason Raleigh Nunn
Hyperion Therapeutics (HPTX)
Director

Not Ranked
Jason Raleigh Nunn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$38M
99.90%
0.08%
0.02%
0.00%
A breakdown of Jason Raleigh Nunn's holdings

Insider Roles

Zenas BioPharma, Inc.
(ZBIO)
Director
Journey Medical Corp
(DERM)
Director
Trevena
(TRVN)
Director
Regulus
(RGLS)
Director
Roles that Jason Raleigh Nunn holds in companies

Most Profitable Insider Trade

Stock:
Zenas BioPharma, Inc.
(ZBIO)
Rating:Informative Buy
Date:Sep 16, 2024 - Today
Return:+16.80%
The most profitable trade made by Jason Raleigh Nunn

Jason Raleigh Nunn's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HPTX
Hyperion Therapeutics
May 11, 2015
Uninformative Sell
123.60K
Regulus
Director
Journey Medical Corp
Director
$31.38K
Zenas BioPharma, Inc.
Sep 16, 2024
Director
Uninformative Buy
$38.06M
Trevena
Dec 10, 2015
Director
Uninformative Buy
$7.18K
TRIV
Trivascular Technologies
$0.00
~DERM
Dermira
$112.50K
PRTK
Paratek Pharmaceuticals
$0.00
List of latest transactions for each holding click on a transaction to see Jason Raleigh Nunn's performance on stock

Jason Raleigh Nunn insider profile FAQ

What is the percentage of profitable transactions made by Jason Raleigh Nunn?
The percentage of profitable transactions made by Jason Raleigh Nunn is ―.
    What is the average return per transaction made by Jason Raleigh Nunn?
    The average return per transaction made by Jason Raleigh Nunn is ―.
      What stocks does Jason Raleigh Nunn hold?
      Jason Raleigh Nunn holds: HPTX, RGLS, DERM, ZBIO, TRVN, TRIV, ~DERM, PRTK stocks.
        What was Jason Raleigh Nunn’s latest transaction?
        Jason Raleigh Nunn latest transaction was an Uninformative Sell of $123.60K.
          What was Jason Raleigh Nunn's most profitable transaction?
          Jason Raleigh Nunn’s most profitable transaction was an Informative Buy of ZBIO stock on September 16, 2024. The return on the trade was 16.80%.
            What is Jason Raleigh Nunn's role in Hyperion Therapeutics?
            Jason Raleigh Nunn's role in Hyperion Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.